Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share Price

Price 13,880.00p on 19-05-2026 at 18:01:23
Change 170.00p 1.24%
Buy 13,880.00p
Sell 13,878.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Unknown 5.00 at 13,840.33242p
Day's Volume: 1,491,117
Last Close: 13,880.00p
Open: 13,738.00p
ISIN: GB0009895292
Day's Range 13,668.00p - 13,912.00p
52wk Range: 10,104.00p - 15,730.00p
Market Capitalisation: £215.26b
VWAP: 13,819.391p
Shares in Issue: 1.55b

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Lower Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Astrazeneca (AZN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 5 13,840.33242p SI Trade
Currency Conversion
 19:01:23 - 19-May-26
Unknown* 0 13,839.58711p SI Trade
Currency Conversion
 19:00:30 - 19-May-26
Unknown* 0 13,835.11528p SI Trade
Currency Conversion
 18:46:07 - 19-May-26
Unknown* 0 13,820.95446p SI Trade
Currency Conversion
 18:44:11 - 19-May-26
Unknown* 0 13,829.89814p Currency Conversion
OTC Trade
 18:32:53 - 19-May-26
Unknown* 0 13,832.13405p SI Trade
Currency Conversion
 18:21:41 - 19-May-26
Unknown* 0 13,844.05895p SI Trade
Currency Conversion
 18:17:23 - 19-May-26
Unknown* 0 13,842.56834p SI Trade
Currency Conversion
 18:11:30 - 19-May-26
Unknown* 0 13,844.80426p SI Trade
Currency Conversion
 18:01:13 - 19-May-26
Unknown* 25 13,835.48793p Currency Conversion
Negotiated Trade
OTC Trade
 17:57:06 - 19-May-26
See more Astrazeneca trades

Astrazeneca (AZN) Share Price History

Time period:
to
Date Open High Low Close Volume
19th May 2026 (Tue) 13,738.00 13,912.00 13,668.00 13,880.00 1,491,117
18th May 2026 (Mon) 13,482.00 13,764.00 13,436.00 13,710.00 1,404,159
15th May 2026 (Fri) 13,800.00 13,862.00 13,528.00 13,632.00 1,864,672
14th May 2026 (Thu) 13,824.00 13,900.00 13,686.00 13,740.00 696,265
13th May 2026 (Wed) 13,674.00 13,814.00 13,584.00 13,766.00 1,571,414
12th May 2026 (Tue) 13,302.00 13,748.00 13,218.00 13,748.00 3,257,436
11th May 2026 (Mon) 13,380.00 13,638.00 13,338.00 13,502.00 3,376,377
8th May 2026 (Fri) 13,342.00 13,466.00 13,188.00 13,344.00 2,521,360
7th May 2026 (Thu) 13,684.00 13,706.00 13,314.00 13,314.00 2,842,072
6th May 2026 (Wed) 13,454.00 13,634.00 13,446.00 13,566.00 1,617,600
5th May 2026 (Tue) 13,564.00 13,566.00 13,276.00 13,330.00 3,363,807
4th May 2026 (Mon) 13,512.00 13,512.00 13,512.00 13,512.00 0
1st May 2026 (Fri) 13,810.00 13,810.00 13,512.00 13,512.00 1,580,341
30th Apr 2026 (Thu) 13,782.00 14,070.00 13,706.00 13,948.00 2,819,765
29th Apr 2026 (Wed) 13,816.00 13,910.00 13,488.00 13,692.00 2,414,183
28th Apr 2026 (Tue) 13,862.00 13,930.00 13,688.00 13,900.00 2,124,265
27th Apr 2026 (Mon) 14,026.00 14,072.00 13,864.00 13,972.00 2,157,259
24th Apr 2026 (Fri) 14,310.00 14,310.00 13,948.00 13,956.00 2,456,514
23rd Apr 2026 (Thu) 14,380.00 14,556.00 14,348.00 14,492.00 2,131,626
22nd Apr 2026 (Wed) 14,534.00 14,640.00 14,484.00 14,536.00 1,456,287
21st Apr 2026 (Tue) 14,740.00 14,894.00 14,494.00 14,560.00 1,917,122
20th Apr 2026 (Mon) 15,076.00 15,108.00 14,882.00 14,952.00 1,172,933
See more Astrazeneca price history

Astrazeneca (AZN) Regulatory News

Date Source Headline
18th May 2026 3:00 pm RNS Director/PDMR Shareholding
18th May 2026 7:05 am RNS Enhertu approved in two HER2+ early BC settings
18th May 2026 7:00 am RNS Baxfendy approved in the US for hypertension
14th May 2026 7:00 am RNS Imfinzi + EV improves EFS & OS in bladder cancer
1st May 2026 3:00 pm RNS Total Voting Rights and Admission of Shares
1st May 2026 7:05 am RNS FDA ODAC vote on camizestrant in breast cancer
1st May 2026 7:00 am RNS FDA ODAC recommends Truqap in prostate cancer
29th Apr 2026 7:00 am RNS 1st Quarter Results
28th Apr 2026 7:00 am RNS Breztri approved in the US for asthma
27th Apr 2026 7:00 am RNS Saphnelo self-administration approved in the US
See more Astrazeneca regulatory news

Astrazeneca (AZN) Share News

US regulator greenlights AstraZeneca's blood pressure drug Baxfendy

18th May 2026 09:47

(Alliance News) - AstraZeneca PLC on Monday reported US clearance for its hypertension treatment Baxfendy. Read More

CORRECT: AstraZeneca bladder cancer trial yields encouraging results

14th May 2026 20:03

(Correction clarifies that the phase III Volga trial was conducted across three arms and provides the findings for arms 1 and 2 versus the comparator arm) Read More

AstraZeneca immunotherapy for stomach cancer green lit for NHS use

14th May 2026 11:13

(Alliance News) - Patients with aggressive stomach cancer are to benefit from a new type of treatment after the NHS spending watchdog approved the first immunotherapy for people with this form of cancer. Read More

AstraZeneca's bladder cancer drug yields encouraging test results

14th May 2026 09:08

(Alliance News) - AstraZeneca PLC on Thursday posted positive trial results for its bladder cancer treatment imfinzi. Read More

AstraZeneca hails phase-3 trial results for hypoparathyroidism drug

12th May 2026 14:22

(Alliance News) - AstraZeneca on Tuesday hailed encouraging test results for its hypoparathyroidism drug eneboparatide. Read More

See more Astrazeneca news
FTSE 100 Latest
Value10,330.55
Change6.80

Login to your account

Forgot Password?

Not Registered